FND Education Project

REFERENCE · RECOVERY TECHNIQUE

Advanced Visual Feedback and Non-Invasive Brain Stimulation: Specialist Review

Most likely fit: A specialist or research team is evaluating an experimental visual-feedback or stimulation approach after discussing uncertainty and alternatives. [Experimental or early clinical-report evidence; no established self-treatment protocol]

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For the Person With FND

What this approach is for

This original entry includes two different possibilities. Advanced visual feedback might use an instrumented task to show a visual response. Non-invasive brain stimulation, such as transcranial magnetic stimulation, applies stimulation outside the head. They are not the same intervention and neither is established routine treatment for functional visual loss.

Ordinary orthoptist-led demonstrations have their own page. This page concerns more specialized proposals and how to assess them, not equipment to buy or a home programme.

Terms in everyday language

Gaze tracking measures where the eyes are directed; it does not directly measure every part of conscious seeing. Transcranial magnetic stimulation (TMS) uses magnetic pulses to influence brain activity. Phosphenes are perceived flashes or patterns that can occur without an external visual object. Producing a phosphene is not the same as restoring reliable everyday vision.

Practical discussion and flare adaptations

Ask which exact method is proposed, what evidence concerns people with your visual presentation, whether it is research, and what will be measured beyond an immediate response. Request a clear account of risks, costs, stopping rules and follow-up.

Do not use consumer electrical devices or magnets to imitate clinical stimulation. A visually provocative app can also be unsuitable. During a familiar flare, use the usual support plan; increasing stimulation or forcing a visual response is not a rescue strategy.

These examples require selection for your assessed presentation. The clinical rationale and its limits are described in the sources below. (Sources: 1, 2)

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Family, Friends, and Other Supporters

Help the person obtain an understandable explanation and avoid pressure to pay for a promised cure. Participation in a study or specialist trial should not become a condition for receiving practical help.

Do not treat an induced flash, recorded eye movement or short-lived change as proof that the person can now safely manage roads, stairs or other visual hazards.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

For Clinicians and the Care Team

Selection and assessment

Keep advanced feedback and TMS as separately specified modalities. For feedback, document device, target response, tolerability and whether useful function changes. For TMS, require trained delivery, formal contraindication and seizure-risk screening, implant review and the service’s safety procedures. A functional-seizure history must not be treated as equivalent to epilepsy or as assurance that epilepsy is absent.

Explicit procedure

  1. Define the modality, intended functional outcome and evidence specific to the visual presentation.
  2. Explain experimental status, alternatives and the distinction between a physiological response and treatment benefit.
  3. For advanced feedback, assess visual-motion, flicker, migraine and cognitive tolerability; do not conceal task interpretation.
  4. For TMS, use the specialist service’s safety screening, consent, monitoring and adverse-event procedures; no settings are prescribed here.
  5. Evaluate immediate and sustained daily-life outcomes separately and retain needed accommodations.
  6. Stop for adverse effects or lack of meaningful benefit; communicate results to the continuing-care clinician.

Review, progression and stopping

Research protocols need appropriate governance and prospective outcomes. Case reports combining explanation, hypnosis and stimulation cannot establish which component caused improvement. A specialist consultation may appropriately conclude that neither modality is suitable. The original combined entry is retained as one review page without claiming a common mechanism.

This is an educational implementation example, not a validated standalone treatment protocol. (Sources: 1, 2)

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —

Research and Sources

The 2024 review discusses advanced feedback as a developing direction and TMS in small clinical reports. These are not validated home treatments. The 2026 synthesis reinforces uncertainty rather than establishing a stimulation dose or a standard device pathway.

Citation Full citation
[1] Ramsay N, McKee J, Al-Ani G, Stone J. How do I manage functional visual loss. Eye. 2024;38:2257–2266. FND-CIT-0024. Source
[2] Ramsay N, Tessmann H, McKee J, Ercoli T, Stone J. Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment. Eye. 2026;40:1784–1793. Published online June 26, 2026. FND-CIT-0103. Source

Source check: September 16, 2026 · Ophthalmology, neuro-ophthalmology, orthoptics, migraine, psychological, lived-experience, supporter and accessibility review pending.

For the Person With FND
For Family, Friends, and Other Supporters
For Clinicians and the Care Team
Research and Sources —